Approval · Notice of Compliance 2996 · 1998
REBIF: Notice of Compliance 2996
Issued February 5, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2996
- Date
- February 5, 1998
- Company
- Serono Canada Inc.
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Immunomodulator
Products in this notice
Medicinal ingredients
- INTERFERON BETA-1A 11 MCG per VIAL
- INTERFERON BETA-1A 44 MCG per VIAL
- INTERFERON BETA-1A 22 MCG per 0.5ML
- INTERFERON BETA-1A 44 MCG per 0.5ML